High Throughput Imaging Speeds Analysis of Hormone Receptors
News Nov 03, 2008
A new high throughput microscopy technique enabled researchers at Baylor College of Medicine in Houston to analyze thousands of individual cells expressing androgen receptor, a finding that could herald new ways of evaluating the effect of drugs or other treatments on cells with normal or aberrant hormone receptors.
In a report in the current issue of Public Library of Science One (PLoS One), Dr. Michael Mancini and his collaborators reported a new, next generation high throughput image-based assay that helps determine the level and location of androgen receptor and its transcriptional activity on a cell-by-cell basis.
"This has application to personalized medicine," said Mancini, associate professor of molecular and cellular biology at BCM and director of its Integrated Microscopy Core. "For example, we could use the high throughput microscope and robust image analysis to determine which drug might be best to turn off or repair a mutated cell that is causing disease."
In this case, he and his colleagues analyzed the androgen receptor, a molecule that binds the hormones testosterone or dihydrotestosterone and is responsible for regulating genes that give an organism or animal male characteristics.
"As our ability to image cells using high throughput microscopy got going faster and faster, we began to collect enormous amounts of functional data that was usually only accessible by separate (and slow) biochemical experiments. Our customized software approaches then allowed us two assemble the results into a more systems-level appreciation of the biology, linking together several functional characteristics of the androgen receptor," he said.
The high throughput technique, often called high content analysis, enables researchers to analyze effects on a cell-by-cell basis, taking into account the heterogeneity of the cells, he said. Before the development of new microscopes, he said, taking a few images an hour was a feat.
"Now we routinely take thousands of pictures a day," said Mancini.
Not only that, but scientists such as Adam Szafran, the M.D./Ph.D. student who is first author of this report, can essentially look at several elements of cellular response at the same time.
"We can study issues dealing with the cell cycle as it goes through its life," said Szafran. Previously, scientists had to manipulate cells to capture them at different points in their lives. The new imaging technology enables them to study the cell in a more natural form.
In the PLoS study, Szafran, Mancini and their colleagues were able to study the response of a particular androgen mutation to different ligands.
"We could show how the receptor was defective in respect to the endogenous (or normally present) ligand. When we used a different ligand, we could rescue aspects of the receptor's function," said Szafran.
The technique could have application in personalizing medicine, said Mancini. Physicians could take the individual cells of a patient diagnosed with a disease and use the high throughput microscope to see how different drugs affect the mutated cells. The high speed approaches for androgen receptor studies are also being used to investigate basic science and personalized medicine possibilities in several other projects, including breast and prostate cancers, and adipose biology.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018